Home Archive
Archive
2024 Volume 55 Issue 6  Published: 2024-06-10
    Perspectives
  • Xi YANG , Huiyi LI
    doi: 10.16522/j.cnki.cjph.2024.06.001

    Amorphous solid dispersion is one of the most effective formulation approaches to enhance the oral bioavailability of poorly water-soluble drugs with wide application prospects. However, due to the “aging”, a solid state physical stability problem, which affects the dissolution in vitro and absorption in vivo, the development of amorphous solid dispersion-based preparations faces great challenges. The solid state physical stability is affected by many factors such as formulation composition, preparation process and storage conditions. In this paper, formulation composition, preparation process and quality control of amorphous solid dispersion-based preparations are summarized in order to provide the guidance for the development of amorphous solid dispersion-based preparations.

  • Review
  • Hao QIAN , Weicheng ZHOU , Zhengyan CAI
    doi: 10.16522/j.cnki.cjph.2024.06.002

    Proteolysis targeting chimeras(PROTACs) are currently one of the hot spots in antineoplastic agent research. They have efficient and durable anti-tumor effects, good selectivity, and low possible toxicity. This review summarizes the research progress of new PROTAC drugs targeting estrogen receptors, androgen receptors, BCR-ABL, histone deacetylase 4, methyltransferase-like 3.

  • Review
  • Luzhuo ZHAO , Jianxin WANG , Jianyong SHENG
    doi: 10.16522/j.cnki.cjph.2024.06.003

    Oral administration is by far the most commonly used route of drug administration. Through the rational design and optimization of oral formulations and their preparation processes, increase of solubility, sustained- and controlled-release of drugs can be achieved, resulting in improved oral bioavailability, enhanced efficacy, reduced toxicity or personalized drug delivery. However, the current formulation and preparation process optimization of oral formulations is still highly dependent on traditional trial-and-error experiments and empirical data, which is time-consuming, laborious, costly, and hardly predictable. Artificial intelligence(AI) technology, which has flourished in recent years, is expected to enable efficient and systematic design of oral formulations. Based on the existing experimental data for oral preparations, a prediction model can be established through AI to predict the relevant indicators of oral preparations and optimize the process parameters of oral preparations. This review summarizes the basic principles and applications of AI-assisted development in oral formulations, discusses and offers prospects on the applications of AI in the field of oral formulations, and provides a reference for accelerating further research and development of pharmaceutical preparations with AI technology.

  • Review
  • Xuan LIU , Jingjing ZHU , Zheng CHEN , Yueying WANG
    doi: 10.16522/j.cnki.cjph.2024.06.004

    In view of the discovery of nitrosamine impurities in angiotensinⅡ receptor antagonists, histamine 2 receptor antagonists, antimicrobial drugs, antidiabetic drugs and other drugs, global regulatory agencies have significantly increased their supervision on nitrosamine impurities. Regulatory agencies in various countries have successively issued the corresponding guiding documents, developed risk assessment methods, and proposed control strategies for nitrosamine impurities in drugs. China has also successively introduced a series of guiding documents that are in line with the international standards to control nitrosamine impurities. However, in practical work, there are still difficulties in the generation pathways, risk assessment, and control strategies for nitrosamine impurities. This article mainly introduces the possible nitrosation pathways and formation causes of nitrosamine impurities in chemical drugs, as well as the overall requirements for the analysis methods. And the risk assessment and control strategies for nitrosamine impurities in chemical drugs proposed by the regulatory agencies in various countries are summarized, which can provide a reference for further research and control of nitrosamine impurities.

  • Paper
  • Haibo LIU , Ming LI , Meihan YAN , Jun HE , Zhefeng WANG
    doi: 10.16522/j.cnki.cjph.2024.06.005

    In this study, the synthetic method of sparsentan(1) was improved. With 4-bromo-3-methylbenzo-nitrile(2) as the starting material, 3-(ethoxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde(6)was obtained via free radical substitution, nucleophilic substitution, cyano reduction, Miyaura borylation. In another way, the condensation of 2-bromobenzenesulfonyl chloride(7) with 3-amino-4,5-dimethylisoxazole(8) was conducted, followed by the amino-protection to give 2-bromo-N-(4,5-dimethylisoxazol-3-yl)-N-[(2-methoxyethoxy)methyl]benzene-sulfonamide(11). Intermediates 6 and 11 reacted via Suzuki coupling reaction to get N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-4'-formyl-N-[(2-methoxyethoxy)methyl]-[1,1'-biphenyl]-2-sulfonamide(12), then the target compound 1 was obtained from compound 12 via reduction, bromination, condensation and deprotection. The total yield was about 43.25%(based on 2) with the purity of 99.5%. The optimized route avoided the usage of the dangerous and toxic reagents such as n-butyl lithium and carbon tetrabromoide, and simplified some purifications.

  • Paper
  • Yu GAO , Guoning ZHANG , Yucheng WANG
    doi: 10.16522/j.cnki.cjph.2024.06.006

    In order to control the quality of fluticasone propionate, the synthesis route of impurity K(1) in EP of fluticasone propionate was designed. An economical and available starting material, dexamethasone (2), was acylated, chlorinated, hydrolyzed and deacetylated to obtain 6α-chloro-9α-fluoro -11β,17α,21-trihydroxy-16α-methyl-androstane-1,4-diene-3,20-dione(5). Then 5 was oxidized by periodic acid followed by the substitution with propionyl chloride to obtain 6α-chloro-9α-fluoro-11β-hydroxy-16α-methyl-17α-propoyloxy-3-oxandrostane-1,4-diene-17β-carboxylic acid(7). Then 7 underwent the rearrangement acylation reaction with N,N-dimethylthioformyl chloride, and then was hydrolyzed under alkaline conditions to obtain 6α-chloro-9α-fluoro-11β-hydroxy-16α-methyl-17α-propoyloxy-3-oxandrostane-1,4-diene-17β-carbothioic acid(9). Finally, the target product 1 was obtained by substituting 9 with bromofluoromethane under alkaline conditions. The total yield was about 48.34% (based on 2) with the purity more than 99%. This synthetic route of 1 was reported at the first time, which had certain reference significance for the synthesis of fluticasone propionate.

  • Paper
  • Chao GAO , Yang CUI , Ruixue PAN , Min XU , Yujuan JIANG
    doi: 10.16522/j.cnki.cjph.2024.06.007

    In order to control the quality of crisaborole(1) and its tablets, six related substances were synthesized based on the synthetic process of 1, namely 3-(4-cyanophenoxy)benzyl acetate(related substance A), 4,4'-di(4-cyanophenoxy)-2,2'-bis(acetoxymethyl)biphenyl(related substance B), 4,4'-di(4-cyanophenoxy)-2,2'-bis(hydroxymethyl)-biphenyl(related substance C), 4-[4-[4-bromo-3-(hydroxymethyl)phenoxy]-3-(hydroxymethyl)phenoxy]benzonitrile(related substance D), 5-[2-(acetoxymethyl)-4-(4-cyanophenoxy)phenoxy]-2-bromobenzyl acetate(related substance E)and 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzoic acid(related substance F). Their structures were confirmed by 1H NMR, 13C NMR and MS, and the purities of all impurities were greater than 97%.

  • Paper
  • Shuliang LI , Xianguang YAN , Hanyue YANG , Qiliang ZHONG
    doi: 10.16522/j.cnki.cjph.2024.06.008

    In order to control the quality of fenofibrate, seven related substances of fenofibrate were prepared, namely 4-chloro-4'-hydroxybenzophenone(related substance A), 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropionic acid(related substance B), methyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate(related substance C), ethyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate(related substance D), 2-[[2-(4-(4-chlorobenzoyl)-phenoxy)-2-methylpropanoyl]oxy]-2-methylpropanoic acid(related substance E), 2-[4-(4-hydroxybenzoyl)phenoxy]-2-methylpropanoic acid(related substance F), 2,2'-[[carbonylbis(4,1-phenylene)]bis(oxy)]bis(2-methylpropanoic acid)(related substance G). Their structures were confirmed by MS and NMR.

  • Paper
  • Dan LIU , Zixiang PENG , Jinbing LIU
    doi: 10.16522/j.cnki.cjph.2024.06.009

    7-[4-(Piperazine-1-yl)butoxy]quinoline-2-(1H)-ketone(1) is a key intermediate of brexpiprazole. In this paper, N-alkylated phthalimide was obtained by the reaction of phthalimide compound with 1,4-dihalobutane. The quinolinone amine derivative was obtained by the etherification with hydroxyquinolinone and Gabriel reaction. The quinolinone amine derivative was cyclized with tert-butyl N,N-bis(2-chloroethyl)carbamate followed by deprotection of Boc with HCl/MeOH to get the target compound 1 with the overall yield of 22% and purity of 99%.

  • Paper
  • Ying LU , Jianwei ZHU
    doi: 10.16522/j.cnki.cjph.2024.06.010

    Mesothelin(MSLN) could be served as an important target for immunotherapy for its wide expression in a variety of solid tumors and less expression in normal mesothelial cells. In this study, a recombinant humanized IgG1 monoclonal antibody(rhMSLN mAb) sequence against MSLN with high affinity was constructed into the mammalian cell expression vector pcDNA3.4, and efficiently expressed by the Expi293F cell line. Then, the affinity of the antibody was assessed by surface plasmon resonance and flow cytometry at the molecular and cellular levels respectively. Lactate dehydrogenase(LDH) release assay was used to identify the antibody-dependent cellular cytotoxicity(ADCC) mediated by the antibody. The results showed that rhMSLN mAb could yield up to 70.2 mg/L under specific conditions by the Expi293F cell line. The affinity to recombinant MSLN was 7.02 nmol/L. The EC50 of ADCC against human gastric carcinoma cell line(NCI-N87 cell) was 2.48×10–3 μg/mL. This study provided explorative support for the development and production of biopharmaceuticals targeting MSLN.

  • Paper
  • Jingjing XUAN , Xiying WU , Jianping QI , Jie ZHUANG
    doi: 10.16522/j.cnki.cjph.2024.06.011

    The aim of this study was to promote the oral absorption of quercetin(1), an insoluble natural component, using choline-based ionic liquids(ILs). Firstly, a series of ILs composed of choline hydroxide(Ch) and various acids[phenylalanine(Phe), geranic acid(Ger), malonic acid(Mal), sorbic acid(Sorb), succinic acid(Suc) and malic acid(Mala)] were synthesized and characterized extensively. According to the solubility of 1 in various ILs, the ILs with the superior solubilization effects on 1 were screened out, which were choline geranate([Ch][Ger]) and choline sorbate([Ch][Sorb]). Then, the in vitro dissolution characteristics and in vivo pharmacokinetic behaviors in SD rats of the above two systems(1-[Ch][Ger] and 1-[Ch][Sorb]) were investigated. The results showed that both 1-[Ch][Ger] and 1-[Ch][Sorb] significantly improved the in vitro dissolution rate of 1, but the dissolution rate of the latter at 20 min was similar to that of 1 bulk drug. With 1 suspension as the control, the relative bioavailabilities of 1-[Ch][Ger] and 1-[Ch][Sorb] were 588.0% and 501.9%, respectively. This study is of instructive significance for the investigation of oral preparations of insoluble natural ingredients.

  • Paper
  • Lingjun ZENG , Hongdu QING , Yuejiao KE , Xin ZHOU
    doi: 10.16522/j.cnki.cjph.2024.06.012

    With hexaminolevulinate(1) as a model drug, the nano cubosomes of 1(1-Cubs) for photodynamic therapy(PDT) were prepared by ultrasonication in this study. With particle size and PDI as evaluation indexes, ultrasonic power, ultrasonic time, mass ratio of glycerol monooleate(GMO) to poloxamer 407(F127), mass ratio of carrier(the total amount of GMO and F127) to drug, and drug concentration were optimized. The effect of the optimal 1-Cubs on the survival rate and ROS content of human epidermal cancer cells(A431 cells) under 635 nm laser irradiation was investigated. Then, the skin permeation behaviors of the products were investigated with SD rats as models, and the cumulative transdermal penetration amount and skin retention amount as evaluation indicators. The results showed that the 1-Cubs prepared at ultrasonic power of 400 W, for 15 min, in a 4∶1 mass ratio of GMO to F127 , in a 5∶1 mass ratio of carrier to drug, and drug concentration of 1% had a significant PDT efficacy and ROS production at the cellular level. The 1-Cubs(with the particle size of less than 200 nm) based nanogel with HPMC as the gel matrix also had better skin permeability to SD rats, which was expected to become an excellent topical preparation for PDT.

  • Paper
  • Jiali XING , Ling LIU , Jingyu TANG , Yuxin LIU , Ligang ZHAO
    doi: 10.16522/j.cnki.cjph.2024.06.013

    Two research approaches(using penetration enhancers individually and in combination) were employed to develop a transdermal drug delivery system of cytisine, with the aim of increasing the transdermal penetration of cytisine.In vitro permeation experiments were conducted using a horizontal double-chamber diffusion cell to evaluate the optimal approach for enhancing cytisine penetration. The preliminary investigation on the transdermal mechanisms involved in the optimal approach was carried out through in vitro release experiments and molecular simulation methods. The results demonstrated that geraniol, menthol, and their combination with isopropyl myristate exhibited a significant enhancement in permeability(P<0.05). Among them, the best enhancement was observed in a system with a combination of 5% geraniol and 5% isopropyl myristate as the enhancers, resulting in a 2.02 times increase in cumulative penetration amount at 24 h compared with the blank group. The in vitro release experiments and molecular simulation revealed that the best combination of penetration enhancers could promote the release of cytisine from patches and bind to skin action sites, thus increasing the penetration of cytisine. This combination is expected to be used as a promising method for cytisine permeation in future investigations.

  • Paper
  • Ziming CHENG , Xue XUE
    doi: 10.16522/j.cnki.cjph.2024.06.014

    A drug delivery system of lipid-coated hollow mesoporous silica nanoparticles for curcumin(CUR-HMSN@lip) was constructed. Its formulation and process parameters were optimized, and its pharmacokinetic behavior in rats was investigated. The obtained CUR-HMSN@lip was characterized by TEM, PXRD, ζ potential, and thermogravimetric analyses, and the results indicated that the curcumin-loaded hollow mesoporous silica nanoparticles(CUR-HMSN) were successfully encapsulated by phospholipids. After orally administered of CUR-HMSN@lip to rats, the pharmacokinetic parameters of curcumin were determined and calculated. The results were as follows: tmax was (1.83±0.41)h, AUClast was (570.82±48.07)h·ng·mL–1, and MRTlast was (5.68±1.21)h. Compared with the CUR-HMSN treatment group, the plasma concentration-time curve of the CUR-HMSN@lip treatment group did not show a double peak phenomenon. The relative bioavailability of CUR-HMSN@lip was 203.8%. It was concluded that the CUR-HMSN@lip delivery system increased the bioavailability of curcumin and improved the burst release of CUR-HMSN.

  • Paper
  • Qinghua GE , Miaomiao XIANG , Jiangang XUAN , Zhou LI , Xiuyuan KANG
    doi: 10.16522/j.cnki.cjph.2024.06.015

    A LC-MS/MS method was established to determine the tetrodotoxin(1) in human plasma. The Waters Atlantis HILIC Silica chromatography column(2.1 mm×100 mm, 3 μm) was used, with the mobile phase of acetonitrile-water-acetic acid. The flow rate was 0.40 mL/min, the column temperature was 40 ℃, and the injection volume was 10 μL. The linear range of this method was 0.02 - 5 ng/mL, and the LLOQ was 0.02 ng/mL. The human pharmacokinetic study of 1 injection was conducted for the first time, and the results were validated to meet the requirements of human pharmacokinetic research. The main pharmacokinetic parameters for a single dose of 3 dose groups(5, 10, and 20 µg) were as follows: the cmax of (0.129 2±0.041 9), (0.253 7±0.036 9) and (0.530 8±0.162 6)ng/mL, the tmax of (0.321±0.144),(0.510±0.313) and (0.541±0.275)h, and the t1/2 of (6.589±2.018), (7.047±2.560) and (6.956±3.225)h, respectively, which provided a reference for the development and clinical application of 1 injection.

  • Paper
  • Yifan HUO , Jiachen XU , Meiqing HUANG , Guofeng WANG , Yunliang QIU
    doi: 10.16522/j.cnki.cjph.2024.06.016

    With the development of gene therapy based on adeno-associated virus(AAV), an important task is to develop a simple, rapid and reliable method for detecting pre-existing anti-AAV antibodies. In this study, a simple and rapid method for the detection of total antibodies(TAb) against AAV8 capsid in serum of rhesus monkeys was developed and confirmed. This method based on enzyme-linked immunosorbent assay(ELISA), and AAV8 capsid was coated on 96-well plate, recombinant protein A/G was used as the detection antibody. The results showed that the multiplicative correction factor of this assay was 1.08 and confirmatory cut point was 29.5%. The screening and confirmatory sensitivities were 43.1 and 76.5 ng/mL, respectively. The positive controls of 1 000, 100, 50 ng/mL were tolerant to 1.25×1010, 3.13×109, 1.56×109 GC/mL AAV8, respectively. Both the coefficients of variation(CV)of intra-run and inter-run met CV≤20.0%. In addition, the method has sufficient selectivity and sample stability, which can be used for TAb detection of pre-existing anti-AAV8 capsid in serum of rhesus monkeys.

  • Pharmaceutical Management & Information
  • De LU , Wenyan XU , Jingchen ZHANG
    doi: 10.16522/j.cnki.cjph.2024.06.017
  • Pharmaceutical Management & Information
  • Subingxing MA , Jinxi DING , Ying CHEN , Fenghong YANG , Wei LI
    doi: 10.16522/j.cnki.cjph.2024.06.018
  • Pharmaceutical Management & Information
  • Hui LI , Jinfang SHENG
    doi: 10.16522/j.cnki.cjph.2024.06.019
  • Pharmaceutical Management & Information
  • Ziyue DANG , Yanlin XIANG , Wei TAN , Dongmei GUO
    doi: 10.16522/j.cnki.cjph.2024.06.020
News